新型冠状病毒预防性疫苗非临床研究评价的考虑
尹华静,王寅,吴爽,戴学栋,孙涛,尹茂山,李峥,王庆利,胡晓敏
摘要(Abstract)：
<正>随着新型冠状病毒(简称新冠)肺炎疫情在全球多点暴发快速蔓延,世界公共卫生安全面临严峻挑战,为应对来势汹汹的疫情,国内外疫苗研发企业迅速启动了新冠疫苗研发。目前在研的新冠疫苗类型多样,包括病毒灭活疫苗、基因工程重组疫苗、病毒载体类疫苗、核酸类疫苗(DNA疫苗和m RNA疫苗)等。从新冠疫情的致死率和导致感染者病情的严重程度,以及目前疫情控制手段和疾病转归情况,推动疫苗研发迫在眉睫。
关键词(KeyWords)：
新型冠状病毒;肺炎;疫苗;非临床研究评价
基金项目(Foundation):
作者(Author):
尹华静,王寅,吴爽,戴学栋,孙涛,尹茂山,李峥,王庆利,胡晓敏
DOI: 10.13200/j.cnki.cjb.003045
参考文献(References)：
- [1]药品审评中心.《预防用疫苗临床前研究技术指导原则》[EB/OL](.2020-04-14)[2010-04-22]. http：//www.cde.org.cn/zdyz.do method=largePage&id=99.
- [2]药品审评中心.《预防用生物制品临床前安全性评价技术审评一般原则》[EB/OL].(2008-09-04)[2020-04-14]. http：//www.cde.org.cn/zdyz.do method=largePage&id=55.
- [3]药品审评中心.《预防用DNA疫苗临床前研究技术指导原则》[EB/OL](.2008-09-04)[2020-04-14]. http：//www.cde.org.cn/zdyz.do method=largePage&id=42.
- [4]药品审评中心.《预防用以病毒为载体的活疫苗制剂的技术指导原则》[EB/OL].(2008-09-04)[2020-04-14]. http：//www.cde.org.cn/zdyz.do?method=largePage&id=43.
- [5]国家药品监督管理局.《预防用含铝佐剂疫苗技术指导原则》[EB/OL].(2019-12-09)[2020-04-14]. http：//www.nmpa.gov.cn/WS04/CL2138/372062.html
- [6] CASTILOW E M,OLSON M R,VARGA S M. Understanding respiratory syncytial virus(RSV)vaccine-enhanced disease[J].Immunol Res,2007,39(1-3):225-239.
- [7] TSENG C T,SBRANA E,IWATA-YOSHIKAWA N,et al. Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus[J]. PloS One,2012,7(4):e35421.
- [8] AGRAWAL A S,TAO X,ALGAISSI A,et al. Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus[J]. Hum Vaccin&Immunother,2016,12(9):2351-2356.
- [9] KITAOKA M,NARITOMI A,HIRAKAWA Y,et al. Transdermal immunization using solid-in-oil nanodispersion with CpG oligodeoxynucleotide adjuvants[J]. Pharm Res,2015,32(4):1486-1492.
- [10] POLEWICZ M,GRACIA A,GARLAPATI S,et al. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies[J]. Vaccine,2013,31(31):3148-3155.
- [11] QIU Y,GUO L,ZHANG S,et al. DNA-based vaccination against hepatitis B virus using dissolving microneedle arrays adjuvanted by cationic liposomes and CpG ODN[J]. Drug Deliv,2016,23(7):2391-2398.
- [12]刘丽，李波.疫苗的非临床安全性研究[J].中国新药杂志，2018(21):2.